Ramlawi Basel, Ramchandani Mahesh, Reardon Michael J
Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US.
Interv Cardiol. 2014 Mar;9(1):32-36. doi: 10.15420/icr.2011.9.1.32.
Since 1960, surgical aortic valve replacement (sAVR) had been the only effective treatment for symptomatic severe aortic stenosis until the recent development of transcatheter aortic valve replacement (TAVR). TAVR has offered an alternative, minimally invasive treatment approach particularly for patients whose age or co-morbidities make them unsuitable for sAVR. The rapid and enthusiastic utilization of this new technique has triggered some speculation about the imminent demise of sAVR. We believe that despite the recent advances in TAVR, surgical approach to aortic valve replacement has continued to develop and will continue to be highly relevant in the future. This article will discuss the recent developments and current approaches for sAVR, and how these approaches will keep pace with catheter-based technologies.
自1960年以来，在经导管主动脉瓣置换术（TAVR）出现之前，外科主动脉瓣置换术（sAVR）一直是治疗有症状的重度主动脉瓣狭窄的唯一有效方法。TAVR提供了一种替代的、微创的治疗方法，特别是对于那些因年龄或合并症而不适合sAVR的患者。这项新技术的迅速且广泛应用引发了一些关于sAVR即将被淘汰的猜测。我们认为，尽管TAVR最近取得了进展，但主动脉瓣置换术的外科手术方法仍在不断发展，并且在未来仍将具有高度相关性。本文将讨论sAVR的最新进展和当前方法，以及这些方法将如何与基于导管的技术并驾齐驱。
